BCP Partnering Portal / SDIX Europe Ltd (An OriGene Company)




SDIX is a wholly owned subsidiary of OriGene technologies specializing in high quality antibody development and manufacturing. The OriGene/SDIX antibody collection includes over 10,000 antibodies with options for large scale production in support of diagnostic reagent manufacturing such as Strep A, cTnI, CRP, Apo A1, ApoB, Immunoglobulins, HPT, Alb, Micro-albumin, and Calibrators. For IHC applications, UltraMAB antibodies are the only class of antibodies validated for mono-specificity. Services include: Proprietary antibody development against membrane targets, large-scale monoclonal antibody (ascites and in vitro) production, polyclonal antibody development, recombinant antibody optimization and long-term supply of goat, sheep, rabbit, mice, rat, guinea pig, and chicken antisera and purified antibodies.
Offering highly sensitive yet cost effective primary antibody and detection solutions to clinical anatomical pathologists
More than 200 different detection kits available including 1 step polymer, 2 step polymer and Biotin-Streptavidin, HRP or AP systems
With product quality and technical support that you can count upon
AOAC, AFNOR, NPIP, FDA approvals for the products
For quality systems please use this link http://www.sdix.com/About-SDIX/Quality-Systems.aspx
ImmunoHistoChemistry
UltraMAB™, Ultra Specific Antibodies for Anatomic Pathology, specificity: tested with High Density Protein Microarray
Current targets of UltraMAb’s include HER2, ALK, Ki67, ERCC1, Beta-Catenin, IDH1 and other important diagnostic targets
Extensive range of high sensitivity polymer detection kits
Where Manufacturers and Channel Partners / Distributors find each other!